Brighthouse Financial Stock Symbol BHF Performance and Statistics

Brighthouse Financial's stock symbol is BHF, and it's listed on the New York Stock Exchange (NYSE).

As of the last update, BHF has a market capitalization of over $6 billion.

The stock has shown a significant decline in value since its IPO in 2017, with a peak price of around $55 per share.

BHF's 52-week low was around $25 per share, indicating a substantial drop in value over the past year.

Brighthouse Financial stock has had a significant impact on investors, with a market cap of $2,854,348,000. This massive market capitalization is a testament to the company's influence in the market.

The stock has traded on the NASDAQ exchange, which is one of the largest and most reputable exchanges in the world. This exchange listing provides Brighthouse Financial with access to a vast pool of potential investors.

Looking at the stock's performance over the past year, we can see that the 52-week high was $54.73, while the 52-week low was $40.00. This indicates a significant range of trading activity.

Here's a breakdown of the stock's performance over different periods:

The stock's beta is 1.08, indicating that it is more volatile than the overall market. This means that investors should be prepared for potentially larger price swings.

Brighthouse Financial's financial performance is expected to grow steadily over the next few years. Revenue is projected to increase from $9,090 in 2025 to $9,651 in 2027.

The company's dividend yield is currently 0.00%, indicating that investors may not expect significant dividend payments in the near future. However, the dividend yield is expected to remain at 0.00% through 2027.

Brighthouse Financial's net profit is expected to grow from $1,151 in 2025 to $1,230 in 2027, with a net profit margin of around 33-34% during this period. The company's net debt is expected to remain stable at $3,155 in 2025.

Here's a summary of Brighthouse Financial's key financial metrics for 2025-2027:

The company's Net Margin % is a staggering -25.78%, indicating it's actually losing money on its sales. This is a major red flag.

The FCF Margin % is also negative, at -0.43%, showing the company is struggling to generate cash from its operations.

ROE % and ROA % are also deeply in the red, at -26.23% and -0.51%, respectively. This means the company is not generating returns on its equity or assets.

On the other hand, the 3-Year ROIIC % is a relatively healthy 0.64%, suggesting that over the long term, the company has been able to generate some returns on its investments.

It's worth noting that the company has only been profitable for 5 years out of the past 10, indicating a relatively short history of profitability.

Here are the key profitability metrics for the company:

Overall, the company's profitability metrics are a significant concern, with negative margins and returns on equity and assets.

The GF Value Rank is a crucial metric in financial analysis, and it's calculated based on several key factors. The current GF Value Rank is not explicitly stated in the provided article section, but we can infer its value by looking at the GF Value Rank column, which is not present in the given section.

The Forward PE Ratio is a key component of the GF Value Rank, and it's currently at 2.41. This is significantly lower than the industry average, indicating that the company's stock is undervalued.

The PE Ratio without NRI is 4.4, which is also lower than the industry average, suggesting that the company's stock is still undervalued.

Here are some key metrics that contribute to the GF Value Rank:

The Shiller PE Ratio is 15.14, which is higher than the industry average, indicating that the company's stock is overvalued. However, the GF Value Rank takes into account multiple factors, including the PS Ratio, PB Ratio, and Price-to-Tangible-Book, which are all currently at 0.64, 0.52, and 0.52, respectively.

The EV-to-EBIT and EV-to-EBITDA are both negative, indicating that the company's stock is undervalued. However, the EV-to-Revenue is 0.9, which is lower than the industry average, suggesting that the company's stock is still undervalued.

The Earnings Yield (Greenblatt) % is -34.01, and the FCF Yield % is -0.7, both of which are significantly lower than the industry average, indicating that the company's stock is undervalued.

Estimates in USD are a crucial aspect of financial analysis. They provide a forecast of a company's future performance, helping investors make informed decisions. In the case of Brighthouse Financial, estimates are available for the years 2025 and 2026.

The average earnings estimate for Brighthouse Financial in 2025 is $4.754 USD, based on 7 analyst estimates. This is a significant improvement from the previous year's estimate of -$8.233 USD. Analysts are also expecting a revenue of $9,270 USD in 2026.

Here's a breakdown of the average earnings estimates for Brighthouse Financial:

Note that these estimates are subject to change and should be taken as a general guide only. It's essential to stay up-to-date with the latest information and adjust your expectations accordingly.

In the world of financial analysis, there are several competitors vying for attention.

One of the key competitors is Bloomberg, a well-established player in the financial data and analytics space.

Bloomberg offers a range of financial analysis tools and services, including real-time market data and news.

Another competitor is Thomson Reuters, a leading provider of financial data and analytics.

Thomson Reuters offers a range of financial analysis tools and services, including financial modeling and forecasting.

Companies like FactSet and S&P Global also offer financial analysis tools and services.

These competitors offer a range of features and functionalities that can help financial analysts make informed decisions.

When analyzing a company's financial performance, one key metric to consider is shareholder returns. Here, we can see that BHF underperformed the US Insurance industry which returned 23.2% over the past year.

Looking at the 7-day returns, BHF had a slight decline of -0.3%, while the US Insurance industry saw a slightly larger decline of -0.8%.

The 1-year returns paint an even clearer picture, with BHF experiencing a significant decline of -9.1% compared to the US Insurance industry's 23.2% gain.

Here's a quick summary of the 7-day and 1-year returns for BHF and the US Insurance industry:

In comparison to the US Market, BHF also underperformed with a 1-year return of -9.1% compared to the US Market's 25.6% gain.